SARS-CoV-2 vaccine
The accelerated response to Covid-19 includes investments in preclinical and clinical testing and manufacture of multiple vaccine candidates.
There is a large global effort to develop vaccines for protection against COVID-19 and at least 19 vaccine candidates.
A COVID‑19 vaccine is a biotechnology product intended to provide acquired immunity against coronavirus disease 2019 (COVID‑19)
Interested in learning whether current clinical programs, research developments, or emerging therapeutic approaches may be relevant to your situation?
Educational and research information only. Individual medical decisions should be made in consultation with qualified healthcare professionals.
